/b/veterinary-nursing-news/posts/dechra-launches-pergocoat-for-equine-cushing-s Dechra has launched Pergocoat, for the treatment of Pituitary Pars Intermedia Dysfunction (PPID), aka equine Cushing’s disease. Pergocoat contains pergolide, a long-acting dopamine receptor agonist. It is available in 0.5mg (off-white) and 1mg (yellowen-USTelligent Community 10